查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1611033

神经血栓清除装置市场规模、份额、趋势分析报告：按产品、最终用途、地区和细分市场预测，2025-2030 年

Neurothrombectomy Devices Market Size, Share & Trends Analysis Report By Product, By End Use, By Region, And Segment Forecast, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 154 Pages | 商品交期: 2-10个工作天内

价格

神经血栓切除术设备市场成长与趋势

Grand View Research, Inc.最新报告显示，预计2030年全球神经血栓切除设备市场规模将达11亿美元，2025年至2030年复合年增长率为6.94%。市场成长受到多种因素的推动，例如中风盛行率的增加、不健康生活方式的增加、微创手术需求的增加以及市场参与企业采取的各种策略性倡议。与传统的开颅手术相比，这些设备简化了伤口缝合，并在创伤治疗更快方面具有记录的优势。这些包括容易进入颅内空间、微创性以及由于与神经血栓切除装置相关的先进设计和功能而简化困难的手术。

此外，所有年龄层的人对更美观、更自然的外观越来越感兴趣，以及微创手术期间更少的失血也是市场成长的关键驱动因素。此类手术预计将比侵入性手术更有助于减少创伤并促进更快的康復。如上所述，随着神经血栓切除装置导致失血更少和恢復更快，对微创手术的需求预计将会增加。此外，采用技术先进的产品和快速的产品核可流程预计将在预测期内推动市场成长。各种其他技术已被用于开发用于治疗 AIS 和相关病症的神经血栓切除装置。例如，2023年6月，Penumbra推出了闪电Bolt7动脉血栓切除系统。该设备有助于区分血块和血流。

神经血栓切除术设备市场报告亮点

  • 从产品来看，由于急性缺血性脑中风盛行率上升以及主要市场参与企业增加产品推出，血栓移除设备将在 2024 年占据市场主导地位，份额为 57.8%。
  • 按最终用途划分，由于医院医疗设施的改善和先进设备的配备，医院细分市场在2024年占据市场主导地位，份额为70.4%。
  • 由于急性缺血性脑中风患者的增加，欧洲在 2024 年以 32.9% 的最大销售份额引领市场。

目录

第一章调查方法和范围

第 2 章执行摘要

第三章神经血栓切除设备市场变数、趋势与范围

  • 市场介绍/系统展望
  • 市场规模及成长前景
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 神经血栓切除术设备市场分析工具
    • 波特的分析
    • PESTEL分析

第四章神经血栓清除装置市场：依产品估算与趋势分析

  • 细分仪表板
  • 神经血栓切除术设备市场：2024 年和 2030 年产品变化分析
  • 凝结猎犬
  • 吸引装置
  • 勒除器

第五章神经血栓清除装置市场：最终用途的估计和趋势分析

  • 细分仪表板
  • 神经血栓切除术设备市场：2024 年和 2030 年最终用途变化分析
  • 医院
  • 急诊室
  • 门诊手术中心

第六章神经血栓清除装置市场：区域、估计和趋势分析

  • 2024 年和 2030 年按地区分類的神经血栓清除设备市场占有率
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 丹麦
    • 瑞典
    • 挪威
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 泰国
    • 韩国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第七章 竞争格局

  • 主要市场参与企业的最新趋势和影响分析
  • 公司分类
  • 企业热力图分析
  • 公司简介
    • Medtronic
    • Stryker
    • Acandis GmbH
    • Phenox GmbH
    • Penumbra
    • Vesalio, LLC.
    • Terumo Corporation
    • MIVI Neuroscience, Inc.
    • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • Rapid Medical
    • Infinity Neuro
Product Code: GVR-2-68038-941-8

Neurothrombectomy Devices Market Growth & Trends:

The global neurothrombectomy devices market size is expected to reach USD 1.1 billion by 2030, registering a CAGR of 6.94% from 2025 to 2030, according to a new report by Grand View Research, Inc. Market growth is being driven by various factors including increasing prevalence of stroke, rising adoption of unhealthy lifestyle, increasing demand for minimally invasive procedures and adoption of various strategic initiatives by market players. Compared to traditional, open surgery, these devices provide advantages that simplify wound closure and permit faster healing, such as easy access to intracranial space, minimum invasion, and simplification of challenging procedures due to advanced designs & features associated with neurothrombectomy devices.

Moreover, increasing concern for a more esthetic and natural appearance in all age groups and less amount of blood loss during minimally invasive surgeries are among the major drivers of market growth. Such procedures are expected to further help lower trauma and facilitate quicker recovery than invasive procedures. Thus, neurothrombectomy devices involve less amount of blood loss and quicker recovery time, which is expected to increase the demand for minimally invasive procedures. Moreover, introduction of technologically advanced products and rapid product approval process are factors expected to fuel market growth over the forecast period. There are various other technologies used in the development of neurothrombectomy devices for the treatment of AIS and its associated symptoms. For instance, In June 2023, Penumbra introduced their lightning Bolt7 arterial thrombectomy system. This device helps identify the difference between a blood clot and blood flow.

Neurothrombectomy Devices Market Report Highlights:

  • Based on products, clot retrievers segment dominated the market in 2024, with a share of 57.8% owing to the rising prevalence of acute ischemic stroke and an increasing number of product launches by key market players.
  • Based on end-use, hospital segment dominated the market in 2024 with a share of 70.4% due to improving health care facilities and the availability of advanced equipment in the hospitals.
  • Europe led the market with the maximum revenue share of 32.9% in 2024, owing to the increasing number of patients suffering from acute ischemic stroke in this region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Neurothrombectomy Devices Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Neurothrombectomy Devices Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of suppliers
      • 3.4.1.2. Bargaining power of buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political Landscape
      • 3.4.2.2. Economic and Social Landscape
      • 3.4.2.3. Technological Landscape
      • 3.4.2.4. Environmental Landscape
      • 3.4.2.5. Legal Landscape

Chapter 4. Neurothrombectomy Devices Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Neurothrombectomy Devices Market: Product Movement Analysis, 2024 & 2030 (USD Million)
  • 4.3. Clot Retrievers
    • 4.3.1. Clot Retrievers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Aspiration/Suction Devices
    • 4.4.1. Aspiration/Suction Devices Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Vascular Snares
    • 4.5.1. Vascular Snares Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Neurothrombectomy Devices Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Neurothrombectomy Devices Market: End Use Movement Analysis, 2024 & 2030 (USD Million)
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Emergency Clinics
    • 5.4.1. Emergency Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Neurothrombectomy Devices Market: Regional Estimates & Trend Analysis

  • 6.1. Neurothrombectomy Devices Market Share, By Region, 2024 & 2030 (USD Million)
  • 6.2. North America
    • 6.2.1. North America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. Key Country Dynamics
      • 6.2.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.2.3. Competitive Scenario
      • 6.2.2.4. U.S. Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Key Country Dynamics
      • 6.2.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.3.3. Competitive Scenario
      • 6.2.3.4. Canada Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Key Country Dynamics
      • 6.2.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.2.4.3. Competitive Scenario
      • 6.2.4.4. Mexico Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. Key Country Dynamics
      • 6.3.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.2.3. Competitive Scenario
      • 6.3.2.4. UK Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Key Country Dynamics
      • 6.3.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.3.3. Competitive Scenario
      • 6.3.3.4. Germany Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. Key Country Dynamics
      • 6.3.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.4.3. Competitive Scenario
      • 6.3.4.4. France Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Key Country Dynamics
      • 6.3.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.5.3. Competitive Scenario
      • 6.3.5.4. Italy Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Key Country Dynamics
      • 6.3.6.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.6.3. Competitive Scenario
      • 6.3.6.4. Spain Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Key Country Dynamics
      • 6.3.7.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.7.3. Competitive Scenario
      • 6.3.7.4. Denmark Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Key Country Dynamics
      • 6.3.8.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.8.3. Competitive Scenario
      • 6.3.8.4. Sweden Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Key Country Dynamics
      • 6.3.9.2. Regulatory Landscape/Reimbursement Structure
      • 6.3.9.3. Competitive Scenario
      • 6.3.9.4. Norway Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Key Country Dynamics
      • 6.4.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.2.3. Competitive Scenario
      • 6.4.2.4. Japan Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. Key Country Dynamics
      • 6.4.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.3.3. Competitive Scenario
      • 6.4.3.4. China Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. Key Country Dynamics
      • 6.4.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.4.3. Competitive Scenario
      • 6.4.4.4. India Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Key Country Dynamics
      • 6.4.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.5.3. Competitive Scenario
      • 6.4.5.4. Australia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. Thailand
      • 6.4.6.1. Key Country Dynamics
      • 6.4.6.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.6.3. Competitive Scenario
      • 6.4.6.4. Thailand Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. South Korea
      • 6.4.7.1. Key Country Dynamics
      • 6.4.7.2. Regulatory Landscape/Reimbursement Structure
      • 6.4.7.3. Competitive Scenario
      • 6.4.7.4. South Korea Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Key Country Dynamics
      • 6.5.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.5.2.3. Competitive Scenario
      • 6.5.2.4. Brazil Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Key Country Dynamics
      • 6.5.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.5.3.3. Competitive Scenario
      • 6.5.3.4. Argentina Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. Key Country Dynamics
      • 6.6.2.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.2.3. Competitive Scenario
      • 6.6.2.4. South Africa Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Key Country Dynamics
      • 6.6.3.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.3.3. Competitive Scenario
      • 6.6.3.4. Saudi Arabia Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. Key Country Dynamics
      • 6.6.4.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.4.3. Competitive Scenario
      • 6.6.4.4. UAE Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Key Country Dynamics
      • 6.6.5.2. Regulatory Landscape/Reimbursement Structure
      • 6.6.5.3. Competitive Scenario
      • 6.6.5.4. Kuwait Neurothrombectomy Devices Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Medtronic
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. Stryker
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. Acandis GmbH
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Phenox GmbH
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Penumbra
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Vesalio, LLC.
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Terumo Corporation
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. MIVI Neuroscience, Inc.
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives
    • 7.4.10. Rapid Medical
      • 7.4.10.1. Participant's Overview
      • 7.4.10.2. Financial Performance
      • 7.4.10.3. Product Benchmarking
      • 7.4.10.4. Recent Developments/ Strategic Initiatives
    • 7.4.11. Infinity Neuro
      • 7.4.11.1. Participant's Overview
      • 7.4.11.2. Financial Performance
      • 7.4.11.3. Product Benchmarking
      • 7.4.11.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviation
  • Table 3 North America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 4 North America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 North America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 6 U.S neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S neurothrombectomy devices, by end use, 2018 - 2030 (USD Million)
  • Table 8 Canada neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 Canada neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 10 Mexico neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Mexico neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 13 Europe neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 15 UK neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 UK neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 17 Germany neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Germany neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 19 France neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 France neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 21 Italy neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Italy neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 23 Spain neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Spain neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Denmark neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Denmark neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 27 Sweden neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Sweden neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 29 Norway neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 30 Norway neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Asia Pacific neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 32 Asia Pacific neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 Asia Pacific neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 34 China neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 35 China neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 36 Japan neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 37 Japan neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 38 India neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 39 India neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Australia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 41 Australia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 42 South Korea neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 43 South Korea neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 44 Thailand neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 45 Thailand neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 46 Latin America neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 47 Latin America neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 48 Latin America neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 49 Brazil neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 50 Brazil neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 51 Argentina neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 52 Argentina neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Middle East & Africa neurothrombectomy devices market, by country, 2018 - 2030 (USD Million)
  • Table 54 Middle East & Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 55 Middle East & Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 56 South Africa neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Africa neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 58 Saudi Arabia neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 59 Saudi Arabia neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 60 UAE neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 61 UAE neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Kuwait neurothrombectomy devices market, by product, 2018 - 2030 (USD Million)
  • Table 63 Kuwait neurothrombectomy devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Neurothrombectomy device market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Consumer behavior analysis
  • Fig. 14 Market driver relevance analysis (Current & future impact)
  • Fig. 15 Market restraint relevance analysis (Current & future impact)
  • Fig. 16 Porter's five forces analysis
  • Fig. 17 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 18 Neurothrombectomy device market: Product movement analysis
  • Fig. 19 Segment dashboard
  • Fig. 20 Neurothrombectomy device market product outlook: Key takeaways
  • Fig. 21 Clot retrievers market, 2018 - 2030 (USD Million)
  • Fig. 22 Aspiration/ suction devices market, 2018 - 2030 (USD Million)
  • Fig. 23 Vascular snares market, 2018 - 2030 (USD Million)
  • Fig. 24 Neurothrombectomy device market: End Use movement analysis
  • Fig. 25 Segment dashboard
  • Fig. 26 Neurothrombectomy device market end use outlook: Key takeaways
  • Fig. 27 Hospital market, 2018 - 2030 (USD Million)
  • Fig. 28 Emergency clinics market, 2018 -- 2030 (USD Million)
  • Fig. 29 Ambulatory Surgical Centers market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional outlook, 2024 & 2030
  • Fig. 31 Regional market dashboard
  • Fig. 32 Regional market place: Key takeaways
  • Fig. 33 North America neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 34 US neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 35 Canada neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 36 Europe neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 37 UK neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 38 Germany neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 39 France neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 40 Italy neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 41 Spain neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 43 Japan neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 44 China neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 45 India neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 47 Australia neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 48 Latin America neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 49 Brazil neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 50 Mexico neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 51 MEA neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 52 South Africa neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 53 Saudi Arabia neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 54 UAE neurothrombectomy devices market, 2018 - 2030 (USD Million)
  • Fig. 55 Company market share analysis, 2024